🎗️Лента новостей
Tampa General Plans Palm Beach County Cancer Center
Tampa General Plans Palm Beach County Cancer Center TBBW
Case CCC Receives Support from Children’s Tumor Foundation and Gateway for Cancer Research for Rare Cancer Treatment Trial
Case CCC Receives Support from Children’s Tumor Foundation and Gateway for Cancer Research for Rare Cancer Treatment Trial Case Western Reserve University
Amgen Highlights New Oncology Research and Small Cell Lung Cancer Data at ESMO 2026
Amgen Highlights New Oncology Research and Small Cell Lung Cancer Data at ESMO 2026 Oncodaily
Nikita Wagle: Advancing Health Equity Through Cancer Disparities Research
Nikita Wagle: Advancing Health Equity Through Cancer Disparities Research Oncodaily
BMS Antibody-Drug Conjugate Iza-Bren Bests Chemotherapy in HR-Positive Breast Cancer
BMS Antibody-Drug Conjugate Iza-Bren Bests Chemotherapy in HR-Positive Breast Cancer GenomeWeb
Адвокаты больной раком Лерчек о ее лечении в Китае и следователе, который не разрешал ей обследоваться
Адвокаты больной раком Лерчек о ее лечении в Китае и следователе, который не разрешал ей обследоваться StarHit
От миллиона до двухсот: как в Кыргызстане пытаются вылечить детский рак
От миллиона до двухсот: как в Кыргызстане пытаются вылечить детский рак Правда.Ру
Study identifies potential new treatment targets for the most common type of bowel cancer
Research published today identifies potential new ways to treat the most common type of colorectal cancer in Ireland. The study, conducted by an international research team led by RCSI University of Medicine and Health Sciences and The Institute of Cancer Research, London, provides a roadmap for repurposing existing…
Real-world results confirm benefit of PSMA therapy for prostate cancer
Real-world results confirm benefit of PSMA therapy for prostate cancer EurekAlert!
Dr Sherry Shen on Histology-Specific Trials in Lobular Breast Cancer
Dr Sherry Shen on Histology-Specific Trials in Lobular Breast Cancer Targeted Oncology
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate that the treatment may be capable of managing cancers that have rebuffed most other interventions, including standard immunotherapy.
Growing Awareness and Funding Cancer Research Through No Shave November – NFCR
Growing Awareness and Funding Cancer Research Through No Shave November – NFCR Oncodaily
OncoDaily Grand Rounds at ESMO 2026: All You Need to Know About Sarcoma
OncoDaily Grand Rounds at ESMO 2026: All You Need to Know About Sarcoma Oncodaily